Huifang Kong

2PUBLICATIONS
11CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|May 06, 2026
Transarterial Chemoembolization Combined with Regorafenib and PD-1 Inhibitor as Second-Line Therapy for Unresectable Hepatocellular Carcinoma.

|Jun 12, 2023
Population Sensitive to Lenvatinib Plus Anti-PD-1 for Unresectable Hepatocellular Carcinoma Infected with Hepatitis B Virus.

Xiujuan Chang, Shumin Yu, Jianzhi Pang

Pageof 1

Frequent Collaborators

2 joint publications

Wei Zhang

2 joint publications

Jiagan Huang

1 joint publications

Xiujuan Chang

1 joint publications

Shumin Yu